ActivistsInvestorsTrumpPoliticiansSerenityCitriniSemianalysisTradeArbitrageSearch

$TOI:NASDAQ · Oncology Institute, Inc.

Conviction from: NASDAQCitrini

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.

More about this company

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-03-25Chernett Jorey10%-owner125,000$388,750Form 4
2026-03-17Chernett Jorey10%-owner398,985$1,225,101Form 4

Citrini Research coverage report library →

ReportDateStance
#110 — I Can See Clearly Now... The Rain Is Gone?2025-11-03LONG
#104 — State of the Themes: Long GOOGL, Asian Outperformance and the Age of Virality2025-08-18LONG
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28LONG
#94 — Thematic Primer: Artificial Intelligence, Phase 22025-04-23LONG
#92 — Market Memo: Talk to Me, Goose2025-04-13LONG
#90 — Market Memo: Insuring Against Insanity2025-03-31LONG
#84 — Market Memo: Healthcare's AI-Powered Trump Card2025-02-09LONG

from2028 — cross-site stock view. Rebuilt at publish time.